Trial tests new combo for Tough-to-Treat breast cancer
Disease control
Terminated
This study tested whether combining two drugs, olinvacimab and pembrolizumab, could help control metastatic triple-negative breast cancer. It was for women who had already tried at least one other treatment for their advanced cancer. The goal was to see if this combination could …
Phase: PHASE2 • Sponsor: PharmAbcine • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC